ADMA Biologics, Inc. (ADMA)
16.84
+1.27
(+8.16%)
USD |
NASDAQ |
Mar 02, 15:08
ADMA Biologics Total Assets (Quarterly) : 633.35M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 21.73M |
| Arcutis Biotherapeutics, Inc. | 432.97M |
| CorMedix, Inc. | 750.86M |
| AtriCure, Inc. | 654.18M |
| Ligand Pharmaceuticals, Inc. | 1.561B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 156.03M |
| Shareholders Equity (Quarterly) | 477.32M |
| Debt to Equity Ratio | 0.1674 |
| Current Ratio | 6.708 |
| Net Debt Paydown Yield | 0.15% |